July 12th, 2023

The G7 leaders of Canada, France, Germany, Italy, Japan, the United Kingdom, and the United States of America and the Presidents of the European Council and European Commission, issued a joint declaration affirming their unwavering commitment to a fr. Read more

July 12th, 2023

Theratechnologies Inc. (Nasdaq: THTX) reported second-quarter fiscal 2023 revenue of $17.549 million, falling short of the consensus estimate of $20.32 million. The company attributes this lower-than-expected revenue to specialty pharmacy inventory a. Read more

July 12th, 2023

Shares of Ault Alliance, Inc. (NYSE American: AULT) surged over 100% in pre-market trading after the company provided a business update highlighting its financial status. With approximately 2.1 million shares outstanding and a book value of around. Read more

July 12th, 2023

The European Commission has given its approval, subject to conditions, for the acquisition of VMware, Inc. (NYSE: VMW) by Broadcom Inc. (Nasdaq: AVGO). The decision follows an in-depth investigation into the proposed acquisition. Broadcom, a US-based. Read more

July 12th, 2023

Caribou Biosciences, Inc. (Nasdaq: CRBU), a company that operates in the field of genome editing and develops CRISPR-based technologies for various applications, was initiated with a Buy rating by Truist, accompanied by a price target of $23.  . Read more

July 11th, 2023

Lockheed Martin Rotary and Mission Systems, a business segment of Lockheed Martin Corporation (NYSE: LMT), has been awarded a firm-fixed-price, cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract worth up to $99 million. The cont. Read more

July 11th, 2023

Shift Technologies, Inc. (Nasdaq: SFT) plans to restructure its workforce to align with its omnichannel sales strategy, aimed to enhance the customer experience, increase efficiency, and focus on core operations by eliminating investment in the deale. Read more

July 11th, 2023

FOR IMMEDIATE RELEASE 2023-128 Washington D.C. / CRWE PRESS RELEASE / July 11, 2023   -   The Securities and Exchange Commission today announced charges against Merrill Lynch, Pierce, Fenner & Smith Incorporated and its parent. Read more

July 11th, 2023

Byrna Technologies Inc. (Nasdaq: BYRN) reported a second-quarter fiscal 2023 loss of $0.05 per share and revenue of $11.51 million. These figures fell short of the consensus estimate, which projected earnings per share of $0.01 on revenue of $12 mill. Read more

July 11th, 2023

Astellas Pharma Inc. and 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT)(4DMT) have entered into a license agreement, allowing the use of 4DMT's intravitreal retinotropic R100 vector for rare monogenic ophthalmic diseases. This includes one initial ge. Read more